Adaptive Biotechnologies Corp — Director's Dealing 2020

Jan 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-01-08

Reporting Person: Taylor Stacy L (SVP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-08	Common Stock	M	662	$6.55	Acquired	1962	Direct
2020-01-08	Common Stock	S	662	$30.00	Disposed	1300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-08	Stock Option (Right to Buy)	$6.55	M	662	Disposed	2028-04-24	Common Stock (52662)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019.

F2: The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.